Pooled efficacy and safety of eslicarbazepine acetate as add‐on treatment in patients with focal‐onset seizures: Data from four double‐blind placebo‐controlled pivotal phase III clinical studies

PURPOSE: Pooled evaluation of the key efficacy and safety profile of eslicarbazepine acetate (ESL) added‐on to stable antiepileptic therapy in adults with focal‐onset seizures. METHODS: Data from 1703 patients enrolled in four phase III double‐blind, randomized, placebo‐controlled studies were poole...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:CNS Neurosci Ther
Auteurs principaux: Elger, Christian, Koepp, Mathias, Trinka, Eugen, Villanueva, Vicente, Chaves, João, Ben‐Menachen, Elinor, Kowacs, Pedro A., Gil‐Nagel, António, Moreira, Joana, Gama, Helena, Rocha, José‐Francisco, Soares‐da‐Silva, Patrício
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2017
Sujets:
Original Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5813188/
https://ncbi.nlm.nih.gov/pubmed/29030894
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.12765
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires